Well known Pharma manufacturer Lupin Ltd. on Wednesday announced the launch of generic ‘favipiravir’ under the name ‘Covihalt’ for treatment of those to develop mild to moderate symptoms of... Read more »
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has announced that it has commenced a Post Marketing Surveillance (PMS) study on FabiFlu® to closely monitor the efficacy and safety... Read more »